Paloma Sánchez‐Mateos

8.7k total citations · 1 hit paper
92 papers, 7.2k citations indexed

About

Paloma Sánchez‐Mateos is a scholar working on Immunology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Paloma Sánchez‐Mateos has authored 92 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 37 papers in Immunology and Allergy and 21 papers in Molecular Biology. Recurrent topics in Paloma Sánchez‐Mateos's work include Cell Adhesion Molecules Research (37 papers), Immunotherapy and Immune Responses (30 papers) and Immune cells in cancer (18 papers). Paloma Sánchez‐Mateos is often cited by papers focused on Cell Adhesion Molecules Research (37 papers), Immunotherapy and Immune Responses (30 papers) and Immune cells in cancer (18 papers). Paloma Sánchez‐Mateos collaborates with scholars based in Spain, United States and Mexico. Paloma Sánchez‐Mateos's co-authors include Francisco Sánchez‐Madrid, Ángel L. Corbí, Miguel Á. del Pozo, Amaya Puig‐Kröger, Rafael Samaniego, Natividad Longo, Elena Sierra‐Filardi, Lorena Sánchez-Martı́n, Carlos Cabañas and Miguel R. Campanero and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paloma Sánchez‐Mateos

87 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis

2011 584 citations Rafael Samaniego, Paloma Sánchez‐Mateos et al. profile →

Peers

Countries citing papers authored by Paloma Sánchez‐Mateos

Since Specialization

Citations

This map shows the geographic impact of Paloma Sánchez‐Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paloma Sánchez‐Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paloma Sánchez‐Mateos more than expected).

Fields of papers citing papers by Paloma Sánchez‐Mateos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paloma Sánchez‐Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paloma Sánchez‐Mateos. The network helps show where Paloma Sánchez‐Mateos may publish in the future.

Co-authorship network of co-authors of Paloma Sánchez‐Mateos

This figure shows the co-authorship network connecting the top 25 collaborators of Paloma Sánchez‐Mateos. A scholar is included among the top collaborators of Paloma Sánchez‐Mateos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paloma Sánchez‐Mateos. Paloma Sánchez‐Mateos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation 2025 ·eLife ·(unknown), Cristina Herrero, (unknown), (unknown), (unknown), Francisco Díaz‐Crespo, (unknown), Rafael Samaniego, (unknown), Eduardo Oliver, (unknown), Ricardo García‐Luján, Paloma Sánchez‐Mateos, Rafaël Delgado, Amaya Puig‐Kröger, Ángel L. Corbí	0
2	Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4+ T-Cell Lymphopenia but Preserved Responses to CMV 2024 ·Vaccines ·(unknown), Eduardo Fernández‐Cruz, Roberto Alonso, (unknown), Rebeca Pérez de Diego, (unknown), Paloma Sánchez‐Mateos, (unknown), (unknown), Juana Gil-Herrera	0
3	Chemokine profiling of melanoma–macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma 2024 ·The Journal of Pathology ·(unknown), (unknown), Elena García‐Martínez, (unknown), (unknown), Iván Márquez‐Rodas, J.A. Avilés-Izquierdo, Paloma Sánchez‐Mateos, Rafael Samaniego	9
4	Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control 2023 ·Journal for ImmunoTherapy of Cancer ·María E. Rodríguez-Ruiz, (unknown), (unknown), Paloma Sánchez‐Mateos, (unknown), (unknown), (unknown), (unknown), Maite Álvarez, Miguel F. Sanmamed, José Luis Perez‐Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero	14
5	CCL20/TNF/VEGFA Cytokine Secretory Phenotype of Tumor-Associated Macrophages Is a Negative Prognostic Factor in Cutaneous Melanoma 2021 ·Cancers ·(unknown), Elena García‐Martínez, (unknown), (unknown), (unknown), María Eugenia Fernández‐Santos, Amaya Puig‐Kröger, (unknown), (unknown), Iván Márquez‐Rodas, J.A. Avilés-Izquierdo, Rafael Samaniego, Paloma Sánchez‐Mateos	16
6	Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma 2021 ·Journal of Investigative Dermatology ·(unknown), Elena García‐Martínez, (unknown), (unknown), J.A. Avilés-Izquierdo, Paloma Sánchez‐Mateos, Rafael Samaniego	13
7	CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma 2018 ·Cancer Immunology Research ·Rafael Samaniego, Alejandra Gutiérrez‐González, (unknown), (unknown), (unknown), (unknown), Iván Márquez‐Rodas, José Antonio Fernández Avilés, Miguel Relloso, Paloma Sánchez‐Mateos	62
8	FRI0062 Synovial fluid treg cells secrete il-17 and at the same time are potent suppressors of tresp cell proliferation, tnf alpha and ifn gamma production 2017 ·Annals of the Rheumatic Diseases ·Marta Benito, (unknown), (unknown), Diana Peiteado, Alejandro Balsa, (unknown), Paloma Sánchez‐Mateos, Amaya Puig‐Kröger, E. Martín‐Mola, (unknown)	0
9	In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins 2015 ·Leukemia ·Mónica Martínez‐Moreno, Magdalena Leiva, Noemí Aguilera‐Montilla, (unknown), (unknown), (unknown), Norma C. Gutiérrez, Roberto Maldonado, Joaquín Martínez‐López, Ismael Buño, José A. García‐Marco, Paloma Sánchez‐Mateos, Andrés Hidalgo, Ángeles García-Pardo, Joaquı́n Teixidó	28
10	Rap1-GTP-interacting Adaptor Molecule (RIAM) Protein Controls Invasion and Growth of Melanoma Cells 2011 ·Journal of Biological Chemistry ·Pablo Hernández-Varas, Georgina P. Coló, Rubén A. Bartolomé, Andrew Paterson, Iria Medraño-Fernández, (unknown), Carlos Cabañas, Paloma Sánchez‐Mateos, Esther M. Lafuente, Vassiliki A. Boussiotis, Staffan Strömblad, Joaquı́n Teixidó	32
11	The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression 2010 ·Blood ·Lorena Sánchez-Martı́n, Ana Estecha, Rafael Samaniego, Silvia Sánchez‐Ramón, Miguel A. Vega, Paloma Sánchez‐Mateos	248
12	Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages 2009 ·Cancer Research ·Amaya Puig‐Kröger, Elena Sierra‐Filardi, Ángeles Domínguez‐Soto, Rafael Samaniego, María Teresa Corcuera, Fernando Gómez, Manohar Ratnam, Paloma Sánchez‐Mateos, Ángel L. Corbí	310
13	Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase–Dependent Melanoma Cell Invasion 2006 ·Cancer Research ·Rubén A. Bartolomé, (unknown), Rafael Samaniego, Paloma Sánchez‐Mateos, Xosé R. Bustelo, Joaquı́n Teixidó	109
14	The Chemokine Receptor CCR7 Activates in Dendritic Cells Two Signaling Modules That Independently Regulate Chemotaxis and Migratory Speed 2005 ·The Journal of Immunology ·Lorena Riol‐Blanco, Noelia Sánchez‐Sánchez, A.L. Torres, Alberto Tejedor, Shuh Narumiya, Ángel L. Corbí, Paloma Sánchez‐Mateos, José Luis Rodrı́guez-Fernández	187
15	Signaling through the Leukocyte Integrin LFA-1 in T Cells Induces a Transient Activation of Rac-1 That Is Regulated by Vav and PI3K/Akt-1 2004 ·Journal of Biological Chemistry ·Lorena Sánchez-Martı́n, Noelia Sánchez‐Sánchez, María Dolores Gutiérrez‐López, Ana I. Rojo, Miguel Vicente‐Manzanares, María José Pérez-Álvarez, Paloma Sánchez‐Mateos, Xosé R. Bustelo, Antonio Cuadrado, Francisco Sánchez‐Madrid, José Luis Rodrı́guez-Fernández, Carlos Cabañas	59
16	DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents 2002 ·The Journal of Immunology ·Miguel Relloso, Amaya Puig‐Kröger, Óscar M. Pello, José Luis Rodrı́guez-Fernández, Gonzalo de la Rosa, Natividad Longo, J. Navarro, María Ángeles Muñoz‐Fernández, Paloma Sánchez‐Mateos, Ángel L. Corbí	252
17	Maturation-Dependent Expression and Function of the CD49d Integrin on Monocyte-Derived Human Dendritic Cells 2000 ·The Journal of Immunology ·Amaya Puig‐Kröger, Francisco Sanz‐Rodríguez, Natividad Longo, Paloma Sánchez‐Mateos, Luisa M. Botella, Joaquı́n Teixidó, Carmelo Bernabéu, Ángel L. Corbí	69
18	Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment? 1996 ·Immunology Today ·Miguel Á. del Pozo, Paloma Sánchez‐Mateos, Francisco Sánchez‐Madrid	87
19	Regulation of integrin function 1996 ·Seminars in Cancer Biology ·Paloma Sánchez‐Mateos, Carlos Cabañas, Francisco Sánchez‐Madrid	65
20	Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. 1989 ·PubMed ·Paloma Sánchez‐Mateos, Marta Cebrián, (unknown), Miguel López‐Botet, Manuel O. Landázuri, Francisco Sánchez‐Madrid	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact